US 12,070,455 B2
Thienopyrrole compounds
Stephen E. Ammann, Foster City, CA (US); Eda Y. Canales, San Mateo, CA (US); Weng K. Chang, San Lorenzo, CA (US); Henok H. Kinfe, Foster City, CA (US); Scott E. Lazerwith, Burlingame, CA (US); Michael L. Mitchell, Castro Valley, CA (US); Yasamin Moazami, Seattle, WA (US); Scott D. Schroeder, Union City, CA (US); and Daniel G. Shore, San Mateo, CA (US)
Assigned to Gilead Sciences, Inc., Foster City, CA (US)
Filed by Gilead Sciences, Inc., Foster City, CA (US)
Filed on Sep. 8, 2022, as Appl. No. 17/930,538.
Claims priority of provisional application 63/242,969, filed on Sep. 10, 2021.
Prior Publication US 2023/0270734 A1, Aug. 31, 2023
Int. Cl. C07D 519/00 (2006.01); A61K 31/437 (2006.01); A61K 31/439 (2006.01); A61K 31/4545 (2006.01); A61K 31/4706 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01)
CPC A61K 31/4545 (2013.01) [A61K 31/437 (2013.01); A61K 31/439 (2013.01); A61K 31/4706 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 519/00 (2013.01)] 29 Claims
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.